Response to clozapine in a clinically identifiable subtype of schizophrenia
Response to clozapine in a clinically identifiable subtype of schizophrenia
By Nancy J. Butcher, Wai Lun Alan Fung, Laura Fitzpatrick, Alina Guna, Danielle M. Andrade, Anthony E. Lang, Eva W. C. Chow and Anne S. Bassett
This study in 40 patients with well-established genetic subtype (22q11.2DS) of schizophrenia (SCZ) found they respond as well to clozapine as those with other forms of SCZ, but they may represent a disproportionate number of those with serious adverse events, primarily seizures.
Read or Buy OnlinePeer Reviewed Article
Issue #: 6
Pages: 484-491
Volume #: 206
Article in: The British Journal of Psychiatry
Published in: 2015